Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes (Q47907647)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 April 2009
edit
Language Label Description Also known as
English
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes
scientific article published on 5 April 2009

    Statements

    Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit